Format

Send to

Choose Destination
Mov Disord. 2005 Mar;20(3):383-5.

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.

Author information

1
Institute for Medical Genetics, University of Tübingen, Tübingen, Germany. daniela.berg@uni-tuebingen.de

Abstract

Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, we provide evidence that the area of SN hyperechogenicity does not change in the course of PD. In conjunction with earlier findings in children and adolescents, this evidence indicates that, from late adolescence onward, this ultrasound finding is a trait marker for nigrostriatal vulnerability.

PMID:
15486999
DOI:
10.1002/mds.20311
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center